Elecsys HIV Signal-to-Cutoff

Supplementary file 3: Data for 28,952 HIV screening tests on 24,556 unique patients using the Roche Diagnostics Elecsys HIV combi PT assay. All laboratory data involve analysis on serum or plasma. Specific data fields include: unique patient identification number (deidentified), whether result was first or only HIV screening test performed for the specific patient within the retrospective timeframe or a repeat test (further indicating days after initial testing), age in years, sex (as recorded in the electronic medical record), clinical location/unit at time of testing (emergency department, infectious disease clinic, obstetrics, inpatient, or outpatient), HIV screening result (negative or positive), and S/CO value.

Supplementary file 4: Data for 163 positive HIV screening tests on 142 unique patients using the Roche Diagnostics Elecsys HIV combi PT assay. All laboratory data involve analysis on serum or plasma. Specific data fields include: unique patient identification number (deidentified), whether result was first or only HIV screening test performed for the specific patient within the retrospective timeframe or a repeat test (further indicating days after initial testing), age in years, sex (as recorded in the electronic medical record), clinical location/unit at time of testing (emergency department, infectious disease clinic, obstetrics, inpatient, or outpatient), S/CO value, result of antibody differentiation assay (Bio-Rad Geenius), results of HIV RNA PCR, days between HIV RNA PCR and the antecedent HIV screen, HIV results classification (Confirmed Positive, Confirmed Positive but Geenius Negative), False Positive/PCR negative, False Positive/PCR not done), and clinical notes.